Expression of RCAS1 in female genital organs

Yoshiaki Kawano, Tsunehisa Kaku, Kenzo Sonoda, Toshio Hirakawa, Hiroaki Kobayashi, Yoshihiro Ohishi, Hitoo Nakano

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Receptor-binding antigen expressed on a human uterine adenocarcinoma cell line, SiSo (RCAS1), has been reported to be a prognostic factor of various malignant tumors, and it has also been proven to induce apoptosis of lymphoid cells. However, its normal distribution and function have not yet been elucidated. The purpose of this study was to disclose the distribution of RCAS1 expression in normal female genital organs. Immunohistochemical staining using anti-RCAS1 and anti-MIB-1 antibodies was performed on 123 surgical specimens of a histologically normal uterus, ovary, or fallopian tube from 66 patients, and the apoptotic index was determined. In uterine cervical glands, the expression of RCAS1 was seen in 93% of the cases, and it was mainly localized in the superficial cervical glands. Near the areas of squamous metaplasia, RCAS1 was strongly expressed in all samples. In the uterine cervical squamous epithelium, RCAS1 was seen in 84% of cases. In the uterine corpus, RCAS1 was seen in 87% of all cases, and it was mainly expressed in the endometrial glands of basalis layer. There was significant positive correlation between age and RCAS1 expression, but no significant difference was found regarding the endometrial status and RCAS1 expression in endometrium. No significant correlation was found between RCAS1 expression and MIB-1 index/apoptotic index. RCAS1 may affect these metaplastic processes and tumor progression.

Original languageEnglish
Pages (from-to)330-334
Number of pages5
JournalInternational Journal of Gynecological Pathology
Volume24
Issue number4
DOIs
Publication statusPublished - Oct 1 2005

Fingerprint

Female Genitalia
Antigen Receptors
Fallopian Tubes
Normal Distribution
Metaplasia
Endometrium
Uterus
Ovary
Neoplasms
Adenocarcinoma
Epithelium
Lymphocytes
Apoptosis
Staining and Labeling
Cell Line
MIB-1 antibody

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Obstetrics and Gynaecology

Cite this

Kawano, Y., Kaku, T., Sonoda, K., Hirakawa, T., Kobayashi, H., Ohishi, Y., & Nakano, H. (2005). Expression of RCAS1 in female genital organs. International Journal of Gynecological Pathology, 24(4), 330-334. https://doi.org/10.1097/01.pgp.0000165204.37574.a5

Expression of RCAS1 in female genital organs. / Kawano, Yoshiaki; Kaku, Tsunehisa; Sonoda, Kenzo; Hirakawa, Toshio; Kobayashi, Hiroaki; Ohishi, Yoshihiro; Nakano, Hitoo.

In: International Journal of Gynecological Pathology, Vol. 24, No. 4, 01.10.2005, p. 330-334.

Research output: Contribution to journalArticle

Kawano, Y, Kaku, T, Sonoda, K, Hirakawa, T, Kobayashi, H, Ohishi, Y & Nakano, H 2005, 'Expression of RCAS1 in female genital organs', International Journal of Gynecological Pathology, vol. 24, no. 4, pp. 330-334. https://doi.org/10.1097/01.pgp.0000165204.37574.a5
Kawano Y, Kaku T, Sonoda K, Hirakawa T, Kobayashi H, Ohishi Y et al. Expression of RCAS1 in female genital organs. International Journal of Gynecological Pathology. 2005 Oct 1;24(4):330-334. https://doi.org/10.1097/01.pgp.0000165204.37574.a5
Kawano, Yoshiaki ; Kaku, Tsunehisa ; Sonoda, Kenzo ; Hirakawa, Toshio ; Kobayashi, Hiroaki ; Ohishi, Yoshihiro ; Nakano, Hitoo. / Expression of RCAS1 in female genital organs. In: International Journal of Gynecological Pathology. 2005 ; Vol. 24, No. 4. pp. 330-334.
@article{c79bd6ebd8c8499ba4d35daaea1a467b,
title = "Expression of RCAS1 in female genital organs",
abstract = "Receptor-binding antigen expressed on a human uterine adenocarcinoma cell line, SiSo (RCAS1), has been reported to be a prognostic factor of various malignant tumors, and it has also been proven to induce apoptosis of lymphoid cells. However, its normal distribution and function have not yet been elucidated. The purpose of this study was to disclose the distribution of RCAS1 expression in normal female genital organs. Immunohistochemical staining using anti-RCAS1 and anti-MIB-1 antibodies was performed on 123 surgical specimens of a histologically normal uterus, ovary, or fallopian tube from 66 patients, and the apoptotic index was determined. In uterine cervical glands, the expression of RCAS1 was seen in 93{\%} of the cases, and it was mainly localized in the superficial cervical glands. Near the areas of squamous metaplasia, RCAS1 was strongly expressed in all samples. In the uterine cervical squamous epithelium, RCAS1 was seen in 84{\%} of cases. In the uterine corpus, RCAS1 was seen in 87{\%} of all cases, and it was mainly expressed in the endometrial glands of basalis layer. There was significant positive correlation between age and RCAS1 expression, but no significant difference was found regarding the endometrial status and RCAS1 expression in endometrium. No significant correlation was found between RCAS1 expression and MIB-1 index/apoptotic index. RCAS1 may affect these metaplastic processes and tumor progression.",
author = "Yoshiaki Kawano and Tsunehisa Kaku and Kenzo Sonoda and Toshio Hirakawa and Hiroaki Kobayashi and Yoshihiro Ohishi and Hitoo Nakano",
year = "2005",
month = "10",
day = "1",
doi = "10.1097/01.pgp.0000165204.37574.a5",
language = "English",
volume = "24",
pages = "330--334",
journal = "International Journal of Gynecological Pathology",
issn = "0277-1691",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Expression of RCAS1 in female genital organs

AU - Kawano, Yoshiaki

AU - Kaku, Tsunehisa

AU - Sonoda, Kenzo

AU - Hirakawa, Toshio

AU - Kobayashi, Hiroaki

AU - Ohishi, Yoshihiro

AU - Nakano, Hitoo

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Receptor-binding antigen expressed on a human uterine adenocarcinoma cell line, SiSo (RCAS1), has been reported to be a prognostic factor of various malignant tumors, and it has also been proven to induce apoptosis of lymphoid cells. However, its normal distribution and function have not yet been elucidated. The purpose of this study was to disclose the distribution of RCAS1 expression in normal female genital organs. Immunohistochemical staining using anti-RCAS1 and anti-MIB-1 antibodies was performed on 123 surgical specimens of a histologically normal uterus, ovary, or fallopian tube from 66 patients, and the apoptotic index was determined. In uterine cervical glands, the expression of RCAS1 was seen in 93% of the cases, and it was mainly localized in the superficial cervical glands. Near the areas of squamous metaplasia, RCAS1 was strongly expressed in all samples. In the uterine cervical squamous epithelium, RCAS1 was seen in 84% of cases. In the uterine corpus, RCAS1 was seen in 87% of all cases, and it was mainly expressed in the endometrial glands of basalis layer. There was significant positive correlation between age and RCAS1 expression, but no significant difference was found regarding the endometrial status and RCAS1 expression in endometrium. No significant correlation was found between RCAS1 expression and MIB-1 index/apoptotic index. RCAS1 may affect these metaplastic processes and tumor progression.

AB - Receptor-binding antigen expressed on a human uterine adenocarcinoma cell line, SiSo (RCAS1), has been reported to be a prognostic factor of various malignant tumors, and it has also been proven to induce apoptosis of lymphoid cells. However, its normal distribution and function have not yet been elucidated. The purpose of this study was to disclose the distribution of RCAS1 expression in normal female genital organs. Immunohistochemical staining using anti-RCAS1 and anti-MIB-1 antibodies was performed on 123 surgical specimens of a histologically normal uterus, ovary, or fallopian tube from 66 patients, and the apoptotic index was determined. In uterine cervical glands, the expression of RCAS1 was seen in 93% of the cases, and it was mainly localized in the superficial cervical glands. Near the areas of squamous metaplasia, RCAS1 was strongly expressed in all samples. In the uterine cervical squamous epithelium, RCAS1 was seen in 84% of cases. In the uterine corpus, RCAS1 was seen in 87% of all cases, and it was mainly expressed in the endometrial glands of basalis layer. There was significant positive correlation between age and RCAS1 expression, but no significant difference was found regarding the endometrial status and RCAS1 expression in endometrium. No significant correlation was found between RCAS1 expression and MIB-1 index/apoptotic index. RCAS1 may affect these metaplastic processes and tumor progression.

UR - http://www.scopus.com/inward/record.url?scp=25444433559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25444433559&partnerID=8YFLogxK

U2 - 10.1097/01.pgp.0000165204.37574.a5

DO - 10.1097/01.pgp.0000165204.37574.a5

M3 - Article

C2 - 16175077

AN - SCOPUS:25444433559

VL - 24

SP - 330

EP - 334

JO - International Journal of Gynecological Pathology

JF - International Journal of Gynecological Pathology

SN - 0277-1691

IS - 4

ER -